Transitional Approaches to Pathogens of Human Significance
Welcome to Rhode Island Hospital’s Pathogen COBRE. We are grateful to the National Institutes of General Medical Sciences of the National Institute of Health for the support for this project.
Directors
Jennifer F Friedman, MD, PhD, MPH
and Jonathan Kurtis, MD, PhD
Leadership Team
Drs. Friedman, Kurtis and Slitt
Contact
Sue Johnson
Program Administrative Coordinator sjohnson18@brownhealth.org
The objectives of NIGM’s COBRE initiative are to strengthen an institution’s biomedical research infrastructure through the establishment of a thematic multidisciplinary center and to enhance the ability of investigators to compete independently for NIH individual research grants or other external peer-reviewed support. COBRE awards are supported through the IDeA Program, which aims to foster health-related research by increasing competitiveness of investigators at institutions located in states with historically low aggregate success rates for grant awards from NIH.
Proposed centers are expected to develop a critical mass of investigators who can secure external funding to support their research programs. Therefore, providing research support and career development guidance to junior investigators must be one of the central focuses of the proposed Center.
Rhode Island Hospital
55 Claverick St.
Suite 101
Providence, RI 02906
This website is supported by the Pathogens COBRE funded by the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM156688. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
CORES RI
CIHR
Pharmacology Core of URI
International Health Institute at Brown Medical School
Global Health Initiative
